Alzheimer's Disease Clinical Trials

Showing 681-700 of 952 trials

Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

NCT01028209

The underlying goal of this study is to assess \[18F\] PBR06 PET imaging as a tool to detect microglial activation in the brain of Alzheimer Disease (AD), Parkinson Disease (PD) and Multiple Sclerosis (MS) research participants.

Alzheimer DiseaseParkinson DiseaseMultiple Sclerosis

Institute for Neurodegenerative Disorders12 participantsStarted Nov 2009

New Haven, Connecticut, United States

TERMINATEDPHASE2

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

NCT02871427

This study seeks to evaluate the long-term safety and effectiveness of nelotanserin for the treatment of visual hallucinations (VHs) and Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) in subjects with Lewy body dementia (LBD).

Lewy Body DementiaDementia With Lewy BodiesParkinson's Disease Dementia+2 more

Axovant Sciences Ltd.80 participantsStarted Oct 2016

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Boca Raton, Florida, United States +16 more locations

Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Related Searches

Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults

Short-term Effects of an Inpatient Geriatric Consultation Team on Geriatric Syndrome Patients

The Efficacy of Traditional Chinese Herbal Medicine for Dementia

EpxCogScreen -- A Phone-based Rapid Cognitive Screen (RCS)

Indiana University Dementia Screening Trial

Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel

Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease

Side Effects of Newer Antipsychotics in Older Adults

A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

Maximizing Independence at Home (MIND at Home)

Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-

Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD

Oxidative Stress and Nutritional Supplementation Intervention Study

Autologous Stem/Stromal Cells in Neurological Disorders and Disease

Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Risk Prediction for Alzheimer Dementia With Brain Imaging and Genetics